190 related articles for article (PubMed ID: 30970262)
1. Genome-Scale CRISPR Screens Identify Human Pluripotency-Specific Genes.
Ihry RJ; Salick MR; Ho DJ; Sondey M; Kommineni S; Paula S; Raymond J; Henry B; Frias E; Wang Q; Worringer KA; Ye C; Russ C; Reece-Hoyes JS; Altshuler RC; Randhawa R; Yang Z; McAllister G; Hoffman GR; Dolmetsch R; Kaykas A
Cell Rep; 2019 Apr; 27(2):616-630.e6. PubMed ID: 30970262
[TBL] [Abstract][Full Text] [Related]
2. A Method to Map Gene Essentiality of Human Pluripotent Stem Cells by Genome-Scale CRISPR Screens with Inducible Cas9.
Mair B; Aregger M; Tong AHY; Chan KSK; Moffat J
Methods Mol Biol; 2022; 2377():1-27. PubMed ID: 34709608
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9 genome editing in human pluripotent stem cells: Harnessing human genetics in a dish.
González F
Dev Dyn; 2016 Jul; 245(7):788-806. PubMed ID: 27145095
[TBL] [Abstract][Full Text] [Related]
4. Essential Gene Profiles for Human Pluripotent Stem Cells Identify Uncharacterized Genes and Substrate Dependencies.
Mair B; Tomic J; Masud SN; Tonge P; Weiss A; Usaj M; Tong AHY; Kwan JJ; Brown KR; Titus E; Atkins M; Chan KSK; Munsie L; Habsid A; Han H; Kennedy M; Cohen B; Keller G; Moffat J
Cell Rep; 2019 Apr; 27(2):599-615.e12. PubMed ID: 30970261
[TBL] [Abstract][Full Text] [Related]
5. p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells.
Ihry RJ; Worringer KA; Salick MR; Frias E; Ho D; Theriault K; Kommineni S; Chen J; Sondey M; Ye C; Randhawa R; Kulkarni T; Yang Z; McAllister G; Russ C; Reece-Hoyes J; Forrester W; Hoffman GR; Dolmetsch R; Kaykas A
Nat Med; 2018 Jul; 24(7):939-946. PubMed ID: 29892062
[TBL] [Abstract][Full Text] [Related]
6. Pipeline for the Generation and Characterization of Transgenic Human Pluripotent Stem Cells Using the CRISPR/Cas9 Technology.
Mianné J; Bourguignon C; Nguyen Van C; Fieldès M; Nasri A; Assou S; De Vos J
Cells; 2020 May; 9(5):. PubMed ID: 32466123
[TBL] [Abstract][Full Text] [Related]
7. Development of drug-inducible CRISPR-Cas9 systems for large-scale functional screening.
Sun N; Petiwala S; Wang R; Lu C; Hu M; Ghosh S; Hao Y; Miller CP; Chung N
BMC Genomics; 2019 Mar; 20(1):225. PubMed ID: 30890156
[TBL] [Abstract][Full Text] [Related]
8. Pooled CRISPR-Based Genetic Screens in Mammalian Cells.
Chan K; Tong AHY; Brown KR; Mero P; Moffat J
J Vis Exp; 2019 Sep; (151):. PubMed ID: 31545321
[TBL] [Abstract][Full Text] [Related]
9. Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus.
Merkle FT; Neuhausser WM; Santos D; Valen E; Gagnon JA; Maas K; Sandoe J; Schier AF; Eggan K
Cell Rep; 2015 May; 11(6):875-883. PubMed ID: 25937281
[TBL] [Abstract][Full Text] [Related]
10. Semi-automated optimized method to isolate CRISPR/Cas9 edited human pluripotent stem cell clones.
Frank E; Cailleret M; Nelep C; Fragner P; Polentes J; Herardot E; El Kassar L; Giraud-Triboult K; Monville C; Ben M'Barek K
Stem Cell Res Ther; 2023 Apr; 14(1):110. PubMed ID: 37106426
[TBL] [Abstract][Full Text] [Related]
11. TALEN- and CRISPR/Cas9-Mediated Gene Editing in Human Pluripotent Stem Cells Using Lipid-Based Transfection.
Hendriks WT; Jiang X; Daheron L; Cowan CA
Curr Protoc Stem Cell Biol; 2015 Aug; 34():5B.3.1-5B.3.25. PubMed ID: 26237572
[TBL] [Abstract][Full Text] [Related]
12. Efficient scarless genome editing in human pluripotent stem cells.
Ikeda K; Uchida N; Nishimura T; White J; Martin RM; Nakauchi H; Sebastiano V; Weinberg KI; Porteus MH
Nat Methods; 2018 Dec; 15(12):1045-1047. PubMed ID: 30504872
[TBL] [Abstract][Full Text] [Related]
13. A Scaled Framework for CRISPR Editing of Human Pluripotent Stem Cells to Study Psychiatric Disease.
Hazelbaker DZ; Beccard A; Bara AM; Dabkowski N; Messana A; Mazzucato P; Lam D; Manning D; Eggan K; Barrett LE
Stem Cell Reports; 2017 Oct; 9(4):1315-1327. PubMed ID: 29020615
[TBL] [Abstract][Full Text] [Related]
14. Protocol for genome-scale CRISPR screening in engineered lineage reporter hPSCs to study cell fate determination.
Zhou Z; Ma L; Zhang X
STAR Protoc; 2021 Jun; 2(2):100548. PubMed ID: 34095862
[No Abstract] [Full Text] [Related]
15. Small molecules promote CRISPR-Cpf1-mediated genome editing in human pluripotent stem cells.
Ma X; Chen X; Jin Y; Ge W; Wang W; Kong L; Ji J; Guo X; Huang J; Feng XH; Fu J; Zhu S
Nat Commun; 2018 Apr; 9(1):1303. PubMed ID: 29610531
[TBL] [Abstract][Full Text] [Related]
16. Engineering Human Stem Cell Lines with Inducible Gene Knockout using CRISPR/Cas9.
Chen Y; Cao J; Xiong M; Petersen AJ; Dong Y; Tao Y; Huang CT; Du Z; Zhang SC
Cell Stem Cell; 2015 Aug; 17(2):233-44. PubMed ID: 26145478
[TBL] [Abstract][Full Text] [Related]
17. Improving single-cell cloning workflow for gene editing in human pluripotent stem cells.
Chen YH; Pruett-Miller SM
Stem Cell Res; 2018 Aug; 31():186-192. PubMed ID: 30099335
[TBL] [Abstract][Full Text] [Related]
18. Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens.
Sharma S; Wright GJ
J Vis Exp; 2020 Jun; (160):. PubMed ID: 32568240
[TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells.
Zhang Y; Sastre D; Wang F
Curr Stem Cell Res Ther; 2018; 13(4):243-251. PubMed ID: 29446747
[TBL] [Abstract][Full Text] [Related]
20. Genome Engineering for Stem Cell Transplantation.
Argani H
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):31-37. PubMed ID: 30777520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
